Prima Biomed Ltd. (PBMD)


NasdaqGM - NasdaqGM Real Time Price. Currency in USD
0.87-0.02 (-2.25%)
At close: 4:00 PM EDT
People also watch:
AVEOCEREOHGIVLTCISR
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open0.90
Prev Close0.89
Bid0.84 x 1000
Ask1.04 x 20000
Day's Range0.85 - 0.90
52wk Range0.72 - 1.73
1y Target EstN/A
Market Cap59.69M
P/E Ratio (ttm)-0.91
Beta0.98
Volume103,891
Avg Vol (3m)178,987
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Marketwired2 days ago

    European Patent Grants for IMP731 Antibody

    Prima BioMed Ltd announces the granting of patent number 2142210 entitled "Cytotoxic anti-LAG-3 monoclonal antibody and its use in the treatment or prevention of organ transplant rejection and autoimmune ...

  • Marketwired9 days ago

    Prima BioMed Ltd: Operational Update

    Prima BioMed Ltd , has provided an update on the Company's cash position and the recruitment progress in its two active clinical trials in IMP321.

  • Marketwired17 days ago

    Prima BioMed Receives NASDAQ Notice of Bid Price Deficiency

    Prima BioMed Ltd , has received notification from the Listing Qualifications Department of The NASDAQ Stock Market indicating that, for the period from June 24, 2016 through August 5, 2016, the closing ...